News Relief Therapeutics Holding SA OTC Markets

Equities

RLFTY

US7595JP3044

Market Closed - OTC Markets Other stock markets 01:21:43 17/05/2024 am IST			5-day change	1st Jan Change
1.42 ^USD	-0.07%		-0.07%	-32.38%

08/05	Relief Therapeutics Restructures Management Team, Creates New Roles	MT
08/05	Relief Therapeutics Announces Executive Changes	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Relief Therapeutics Restructures Management Team, Creates New Roles	08/05	MT
Relief Therapeutics Announces Executive Changes	08/05	CI
Relief Therapeutics Holding SA Announces Chief Financial Officer Changes	08/05	CI
Relief Therapeutics Holding SA Reports Earnings Results for the Full Year Ended December 31, 2023	30/04	CI
Relief Therapeutics' FY23 Loss Widens; Revenue Edges Down	30/04	MT
RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting	28/03	AQ
Sector Update: Health Care Stocks Steady Pre-Bell Friday	22/03	MT
Sector Update: Health Care	22/03	MT
Eton Pharmaceuticals Acquires US Rights to Phenylketonuria Dietary Management Product	22/03	MT
Relief Therapeutics Grants Eton Pharmaceuticals Exclusive License for US Commercialization of Golike	22/03	MT
Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE	22/03	CI
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	22/03	AQ
Relief Therapeutics Extends CHF50 Million Share Subscription Facility with Largest Shareholder	28/02	MT
Relief Therapeutics Holding SA announced that it expects to receive CHF 50 million in funding from Global Emerging Markets and another investor	28/02	CI
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth	06/12	AQ
Relief Therapeutics to Run Commercial Operations Via Partnership Model	05/12	MT
Relief Therapeutics Announces CEO Transition	23/11	AQ
Relief Therapeutics CEO to Leave; Interim Successor Takes Over	22/11	MT
Relief Therapeutics Holding Sa Announces CEO Changes	22/11	CI
Relief Therapeutics announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone	11/23/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Relief Therapeutics Holding SA OTC Markets

Equities

RLFTY

US7595JP3044

Summary

Filters